Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics.

Frontiers in immunology - 1 Jan 2026

Xue Xia, Liu Chang, Qiu Chunjing, Liu Simeng, Liu Fei, Li Ya

Abstract excerpt

Myasthenia gravis (MG) is a chronic autoimmune disorder of the neuromuscular junction characterized by fluctuating skeletal muscle weakness. Although the pathogenic roles of autoantibodies targeting the acetylcholine receptor (AChR), muscle-specific kinase (MuSK), and certain neuromuscular junction proteins have been well established, increasing evidence indicates that MG onset, progression, and therapeutic...

Read the complete abstract on PubMed

Topics

Precision Medicine
Myasthenia Gravis
Genetic Heterogeneity
Cellular Microenvironment
Biomarkers
Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Humans

Source

Open in PubMed Open full text

Identifiers

PMID: 42694599
DOI: 10.3389/fimmu.2026.1932949
PMCID: PMC13539138

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics.PMID 42694599Read ↗

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read ↗

Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signatureSemantic proximity Read ↗

Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review).Semantic proximity Read ↗

Myasthenia gravis: from autoantibodies to therapy.Semantic proximity Read ↗

Epigenetic dysregulation of Th2 cytokine genes in MuSK myasthenia gravis and its modulation by immunosuppressive therapySemantic proximity Read ↗

The epidemiology of myasthenia gravis.Semantic proximity Read ↗

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized MedicineSemantic proximity Read ↗

Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravisSemantic proximity Read ↗

Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep SequencingSemantic proximity Read ↗

Elucidating genetic backgrounds of myasthenia gravis in Japanese by genome-wide association studies and multi-omics analyses of thymoma.Semantic proximity Read ↗

Extensive Clinical Flow Cytometric Lymphocyte Phenotyping in Myasthenia Gravis: A Single-Center Study.Semantic proximity Read ↗

A genome-wide association study of myasthenia gravis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.